Womens experience of Manual Vacuum Aspiration: An Irish perspective

Hayes‐Ryan, Deirdre; Meaney, Sarah; Byrne, Sonia; Ramphul, Meenakshi; O’Dwyer, Vicky; Cooley, Sharon

doi:10.1016/j.ejogrb.2021.09.008

Cited by 3 publications

(7 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, a separate qualitative study of patient experience and satisfaction with the service has been published by this group. 10 Demographics and referral source of the women opting for MVA are presented in Table 1. Patient age ranged from 21 to 46 years, with a median age of 33.5 years.…”

Section: Materials S and Me Thodsmentioning

confidence: 99%

“…Ireland's first MVA clinic was established at the Rotunda Maternity Hospital, Dublin, in April 2020. In March 2020, a working group was established with representatives from Obstetrics and Gynecology, Pharmacy and Midwifery 10 . This group developed a standard operating procedure (SOP) and a patient information leaflet (PIL), which were then reviewed and approved by hospital management 10 .…”

Section: Introductionmentioning

confidence: 99%

“…In March 2020, a working group was established with representatives from Obstetrics and Gynecology, Pharmacy and Midwifery 10 . This group developed a standard operating procedure (SOP) and a patient information leaflet (PIL), which were then reviewed and approved by hospital management 10 . The outpatient ambulatory unit was identified as a suitable clinical area within the hospital, given that most of the necessary infrastructure required was already in place.…”

Section: Introductionmentioning

confidence: 99%

“…10 This group developed a standard operating procedure (SOP) and a patient information leaflet (PIL), which were then reviewed and approved by hospital management. 10 The outpatient ambulatory unit was identified as a suitable clinical area within the hospital, given that most of the necessary infrastructure required was already in place. A supply company was contracted for procurement of disposable instruments, thus eliminating the costs related to sterilization of instruments.…”

mentioning

confidence: 99%

“…A supply company was contracted for procurement of disposable instruments, thus eliminating the costs related to sterilization of instruments. 10 Prior to attending for MVA, all patients receive a pre-pack of medication which included: misoprostol 400 μg to be taken 1e hour pre-procedure, oral analgesia; ibuprofen 800 mg or paracetamol 1 g, and a 3-day course of oral azithromycin for antibiotic prophylaxis.…”

mentioning

confidence: 99%

See 4 more Smart Citations

Audit of Ireland's first manual vacuum aspiration service

Corcoran

Hayes‐Ryan

O’Dwyer

et al. 2023

Intl J Gynecology & Obste

Self Cite

View full text Add to dashboard Cite

IntroductionManual vacuum aspiration (MVA) is a safe and effective alternative option for the management of first‐trimester miscarriage, termination of pregnancy, or retained pregnancy tissue. Ireland's first MVA clinic was set up in the Rotunda Hospital in April 2020.ObjectiveTo identify the number of women who have undergone MVA since establishing our service, to assess the efficacy and safety of MVA in that service, and to develop local Irish studies that further support the safety of MVA, adding to the international body of evidence.MethodsWith the approval and assistance of the Clinical Audit Committee, we obtained a log of all patients who underwent MVA in the first 18 months of the service. We performed a retrospective electronic chart review using Maternal and Newborn Clinical Management System. We collected the data and preformed a descriptive analysis.ResultsIn total, 86 women underwent MVA, 85 (98.8%) of which were successfully completed. There were no immediate procedural complications, inter‐hospital transfers, or emergency electric vacuum aspiration (EVA) required. We obtained an incomplete evacuation rate of 4.7% (n = 4).ConclusionWe have demonstrated that the MVA service in the Rotunda Hospital is a safe, effective management option with advantages for both the patient and the healthcare system. We recommend consideration for provision of funding and resources to enable expansion of this service nationally in order to give women greater autonomy of choice in the management of early pregnancy complications and termination of pregnancy.

show abstract

Section: Materials S and Me Thodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Audit of Ireland's first manual vacuum aspiration service

Corcoran

Hayes‐Ryan

O’Dwyer

et al. 2023

Intl J Gynecology & Obste

Self Cite

View full text Add to dashboard Cite

show abstract

Comparison of misoprostol and manual vacuum aspiration in treating first-trimester incomplete miscarriage: a systematic review and meta-analysis of randomized controlled trials

Jin,

Zhang,

Yang

et al. 2023

Preprint

View full text Add to dashboard Cite

Background To provide evidence of the comparative curative efficiency and prevalence of treatment-related adverse events following manual vacuum aspiration (MVA) or misoprostol in first trimester incomplete abortion.Methods We comprehensively searched international medical literature databases, including PubMed, Medline, Ovid, Embase, and Web of science for related articles published between 2005 and 2023. After article screening, seven articles were finally included in the meta-analysis after assessment for risk of bias. Important parameters of the included studies were strictly extracted. Stata 17MP was used to compare the proportion of complete uterine evacuation, necessity for additional MVA, prevalence of adverse effects (abdominal pain, bleeding, fever, chills, nausea and vomiting), patients’ subjective evaluation and publication bias. Meta-regression was also performed.Results Seven eligible studies of 1097 patients receiving misoprostol and 1079 patients receiving MVA were included, and MVA was found to have better performance than misoprostol in terms of complete uterine evacuation (RR = 0.972, P༜0.001), regardless of age, gestational age, parity, dosage of misoprostol, and marital status. Meanwhile, misoprostol was related to higher possibility for additional MVA (RR = 7.112, P༜0.001). In terms of adverse events, misoprostol medication led to more frequent bleeding (RR = 1.91, P༜0.001), chills (RR = 7.5, P = 0.018), fever (RR = 4.34, P = 0.001), nausea (RR = 3.13, P = 0.005), and vomiting (2.21, P = 0.008).Conclusion MVA outperformed misoprostol in terms of accomplishing complete uterine evacuation in patients with first-trimester incomplete miscarriage. Moreover, the occurrence rate of adverse events was lower in MVA group than that in misoprostol group. However, since the rate of complete uterine evacuation after MVA and misoprostol were both over 90%, misoprostol was also considered as an alternative for MVA in limited resources settings.Trial registration: The research was formally registered on International Platform of Registered Systematic Review and Meta-analysis Protocols (registration number: INPLASY202350113) before statistical analysis.

show abstract